{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:22:30Z","timestamp":1787023350059,"version":"build-2736575974"},"reference-count":36,"publisher":"Media Sphere Publishing House","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vestn. oftal'mol."],"published-print":{"date-parts":[[2021]]},"DOI":"10.17116\/oftalma2021137052340","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T14:20:26Z","timestamp":1634739626000},"page":"340","source":"Crossref","is-referenced-by-count":8,"special_numbering":"Vyp. 2","title":["Modern treatment of different forms of optic nerve atrophy"],"prefix":"10.17116","volume":"137","author":[{"given":"A.K.","family":"Drakon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.V.","family":"Kosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.M.","family":"Sheludchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.B.","family":"Korchazhkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6743","reference":[{"key":"key-10.17116\/oftalma2021137052340-1","unstructured":"Morozov VI, Yakovlev AA. Zabolevaniya zritelnogo puti. Klinika. Diagnostika. Lechenie. M.: Binom; 2010. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-2","unstructured":"Kurisheva NI. Secondary neuroprotection in glaucoma. Medical Council. 2008;3(4):76-77. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-3","unstructured":"Linnik LF, Shigina NA, Oglezneva OK. Visual function restoration in patients with partial optic nerve atrophy after neuroinfection by electric and magnetic stimulation. Oftalmokhirurgiya. 1993;1:47-54. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-4","doi-asserted-by":"crossref","unstructured":"Rose FC. Optical atrophy. Postgrad Med J. 1964;40:692-695","DOI":"10.1136\/pgmj.40.470.692"},{"key":"key-10.17116\/oftalma2021137052340-5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2010.03.005"},{"key":"key-10.17116\/oftalma2021137052340-6","unstructured":"Lyamina NP, Pilyavsky BG. The interval hypoxic training for the treatment of cardiac rhythm disorders in patients with neurocirculatory dystonia. Hypoxia Medical Journal. 1995;1:18-19"},{"key":"key-10.17116\/oftalma2021137052340-7","unstructured":"Kryzhanovsky GN. Obshchaya patofiziologiya nervnoj sistemy. M.: Meditsina; 1997:352-352. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-8","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2012.12.001"},{"key":"key-10.17116\/oftalma2021137052340-9","unstructured":"Mitaev IA, Makkaeva SM, Shilova MA, Puzin MN. Characteristics of lesions of the visual analyzer in patientswith cerebral atherosclerosis. Klinicheskaya nevrologiya. 2019;1:26-30. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-10","unstructured":"Antonova AI, Vasilenko IV. Some pathogenetic mechanisms of the optic nerve impairment in acute vascular optic neuropathies. Vestnik oftal\u2019mologii. 1989;6:7-10. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-11","doi-asserted-by":"crossref","unstructured":"Mayer Calcium FB. Neuronal hyperexitability and ischemic injury. Brain Research Review. 1989;14:227-243","DOI":"10.1016\/0165-0173(89)90002-7"},{"key":"key-10.17116\/oftalma2021137052340-12","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(91)32341-8"},{"key":"key-10.17116\/oftalma2021137052340-13","doi-asserted-by":"crossref","unstructured":"Shimizu T, Wolfe LS. Arachidonic acid cascade and signal transduction. Journal of Neurochemistry. 1990;55:1-15","DOI":"10.1111\/j.1471-4159.1990.tb08813.x"},{"key":"key-10.17116\/oftalma2021137052340-14","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1977.04450080168023"},{"key":"key-10.17116\/oftalma2021137052340-15","unstructured":"Kurysheva NI. Glaukomhnaya opticheskaya nejropatiya. M.: MEDpress-inform; 2006. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-16","unstructured":"Linnik LF, Anisimov SI. Classification of partial optic nerve atrophy. Oftal\u2019mokhirurgiya. 1994;4:14-17. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-17","unstructured":"Serova NK, Lazareva LA, Eliseeva NM. Ophthalmic symptomatology of the visual pathway lesion in traumatic brain injury. Vestnik oftal\u2019mologii. 1994; 3:10-11. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-18","unstructured":"Brovkina AF, Shchuko GA. On differentiated diagnostics of some types of optical neuropathy. RMZh. Klinicheskaya oftal\u2019mologiya. 2008;1:30-32. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-19","doi-asserted-by":"publisher","DOI":"10.15587\/2313-8416.2015.50137"},{"key":"key-10.17116\/oftalma2021137052340-20","doi-asserted-by":"crossref","unstructured":"Burk ROW, V\u00f6lcker HE. Current imaging of the optic disk and retinal nerve fiber layer. Curr Opin Ophthalmol. 1996;1:99-100","DOI":"10.1097\/00055735-199604000-00017"},{"key":"key-10.17116\/oftalma2021137052340-21","unstructured":"Golod NM. On the classification of the optic nerve atrophy. Oftal\u2019mologicheskij zhurnal. 1969;5:384-385. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-22","unstructured":"Miroshnikova LM. Etiology, clinical forms and outcomes of optic nerve diseases. Oftal\u2019mologicheskij zhurnal. 1986;1:41-44. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-23","unstructured":"Gustov AV, Sigriansky KI, Stolyarova ZhP. Prakticheskaya nejrooftal\u2019mologiya. Tom 2. Nizhny Novgorod: NGMA; 2003. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-24","unstructured":"Tron EZh. Zabolevaniya zritel\u2019nogo puti. M.: Meditsina; 1968. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-25","unstructured":"Duginov AG, Ioyleva EE, Shatskikh AV, Zelentsov SN, Didenko TV. Experimental and clinical justification of combined treatment of partial optic nerve atrophy. Oftal\u2019mokhirurgiya. 2008;5:24-28. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-26","doi-asserted-by":"publisher","DOI":"10.3109\/00207459808986429"},{"key":"key-10.17116\/oftalma2021137052340-27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001430.pub4"},{"key":"key-10.17116\/oftalma2021137052340-28","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.15836"},{"key":"key-10.17116\/oftalma2021137052340-29","unstructured":"Kolomoitseva EM, Ermakova VN, Abdulkadyrova MZh. Results of POAG patients treatment with Pikamilon. Vestnik oftal\u2019mologii. 1994;4:4-7. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-30","unstructured":"Kurysheva NI, Shpak AA, Ioyleva EE. \u201cSemaks\u201d in treatment of glaucomatous optic neuropathy in patients with normalized ophthalmotonus. Vestnik oftal\u2019mologii. 2001;4:5-8. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-31","unstructured":"Alekseev IB, Lomakina OE, Shinalieva ON. Efficacy of Semax 0.1% medication as a neuroprotective therapy in glaucoma patients. Glaukoma. 2012; 1:48-52. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-32","unstructured":"Polunin GS, Nurieva SM, Bayandin DL, Sheremet NL, Andreeva LA. Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease. Vestnik oftal\u2019mologii. 2000;116(1):15-18. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-33","doi-asserted-by":"crossref","unstructured":"Strakhov VV, Popova AA, Fedorov VN. The results of Semax neuroprotective efficacy investigation. Oftal\u2019mologicheskie vedomosti. 2014;7(4):43-51. (In Russ.)","DOI":"10.17816\/OV2014443-51"},{"key":"key-10.17116\/oftalma2021137052340-34","unstructured":"Polunin GS, Nurieva SM, Sheremet NL. Sredstvo i sposob lecheniya nevritov zritel\u2019nogo nerva vospalitel\u2019noj, toksiko-allergicheskoj, sosudistoj etiologii i atrofii zritel\u2019nogo nerva. Patent Rossii \u2116 RU 2157258 C1. 1999. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-35","unstructured":"Zamarayeva LV, Gibadullin SA. Kompleksnoe lechenie atrofii zritel\u2019nogo nerva i tapetoretinal\u2019nykh abiotrofij elektronejrostimulyatsiej v sochetanii s blokadoj krylonebnogo gangliya. Tezisy dokladov VI s\u201dezda oftal\u2019mologov Rossii. 1994:95-96. (In Russ.)"},{"key":"key-10.17116\/oftalma2021137052340-36","unstructured":"Kamenskikh TG. Kliniko-funktsional\u2019nye rezul\u2019taty kompleksnoj terapii pri chastichnoj atrofii zritel\u2019nogo nerva razlichnogo geneza. Rostov-on-Don. 1994:21-24. (In Russ.)"}],"container-title":["Vestnik oftal'mologii"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T14:28:06Z","timestamp":1634740086000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/vestnik-oftalmologii\/2021\/5-2\/10042465X2021052340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"alternative-id":["10.17116\/oftalma2021137052340"],"URL":"https:\/\/doi.org\/10.17116\/oftalma2021137052340","relation":{},"ISSN":["0042-465X"],"issn-type":[{"value":"0042-465X","type":"print"}],"subject":[],"published":{"date-parts":[[2021]]}}}